Literature DB >> 18495696

Normalization of catecholamine production following resection of phaeochromocytoma positively influences carotid vascular remodelling.

Giampaolo Bernini1, Fabio Galetta, Ferdinando Franzoni, Michele Bardini, Chiara Taurino, Angelica Moretti, Matteo Bernini, Piero Berti, Paolo Miccoli, Antonio Salvetti.   

Abstract

OBJECTIVE: To evaluate the influence of plasma catecholamines on the vascular structure in humans, the effects of catecholamine normalization on the carotid wall of patients with phaeochromocytoma (PHEO) were investigated. A prospective study in patients with PHEO before and after (first follow-up: 20.5+/-1.8 months, second follow-up: 31.5+/-2.2 months) successful surgery was conducted in the University Referral Center for Blood Pressure Diseases. Ten consecutive patients with PHEOs and ten age- and blood pressure-matched controls were investigated. Intima-media thickness (IMT) by two-dimensional conventional ultrasonography and corrected ultrasonic integrated backscatter signal (C-IBS) analysis of carotid arteries were investigated in basal conditions and after mass removal.
RESULTS: In PHEOs, at variance with the expected reduction in metanephrines and catecholamines, no variation in body weight, blood pressure and lipid profile was observed after operation. IMT and C-IBS values in patients with PHEO were greater (at least P<0.01) than in controls. At long-term follow-up after surgery, a significant reduction in mean carotid IMT (P<0.0009) and C-IBS (P<0.009) values was observed. A significant correlation (r=0.54, P<0.03) was found between absolute reduction in C-IBS values and absolute decrement in urinary normetanephrine levels.
CONCLUSIONS: Our study shows that normalization of catecholamine levels after the removal of PHEO improves carotid IMT and reduces carotid wall fibrosis even without influencing blood pressure and lipid profile. These findings confirm that high catecholamine tone in humans directly influences vascular remodelling of carotid arteries.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18495696     DOI: 10.1530/EJE-08-0126

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  2 in total

1.  Rosuvastatin prevents angiotensin II-induced vascular changes by inhibition of NAD(P)H oxidase and COX-1.

Authors:  Rocchina Colucci; Matteo Fornai; Emiliano Duranti; Luca Antonioli; Ilaria Rugani; Fatma Aydinoglu; Chiara Ippolito; Cristina Segnani; Nunzia Bernardini; Stefano Taddei; Corrado Blandizzi; Agostino Virdis
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

2.  The stress-related hormone norepinephrine induced upregulation of Nix, contributing to ECM protein expression.

Authors:  Weili Liu; Xinxing Wang; Jingbo Gong; Zhusong Mei; Xiujie Gao; Yun Zhao; Jing Ma; Lingjia Qian
Journal:  Cell Stress Chaperones       Date:  2014-05-07       Impact factor: 3.667

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.